Green Alpha Advisors’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $260K | Sell |
22,456
-1,514
| -6% | -$17.5K | 0.25% | 87 |
|
|
2025
Q1 | $209K | Sell |
23,970
-757
| -3% | -$6.61K | 0.22% | 95 |
|
|
2024
Q4 | $355K | Buy |
+24,727
| New | +$355K | 0.28% | 106 |
|
|
2024
Q2 | – | Sell |
-5,713
| Closed | -$214K | – | 142 |
|
|
2024
Q1 | $214K | Buy |
5,713
+60
| +1% | +$2.25K | 0.16% | 130 |
|
|
2023
Q4 | $316K | Sell |
5,653
-2,834
| -33% | -$159K | 0.23% | 129 |
|
|
2023
Q3 | $350K | Sell |
8,487
-2,311
| -21% | -$95.3K | 0.27% | 117 |
|
|
2023
Q2 | $603K | Buy |
10,798
+436
| +4% | +$24.3K | 0.4% | 98 |
|
|
2023
Q1 | $578K | Sell |
10,362
-345
| -3% | -$19.2K | 0.41% | 96 |
|
|
2022
Q4 | $390K | Buy |
10,707
+890
| +9% | +$32.4K | 0.32% | 109 |
|
|
2022
Q3 | $280K | Sell |
9,817
-1,676
| -15% | -$47.8K | 0.24% | 128 |
|
|
2022
Q2 | $520K | Buy |
11,493
+3,492
| +44% | +$158K | 0.12% | 126 |
|
|
2022
Q1 | $609K | Buy |
8,001
+1,049
| +15% | +$79.8K | 0.41% | 101 |
|
|
2021
Q4 | $1.04M | Buy |
6,952
+664
| +11% | +$99K | 0.7% | 69 |
|
|
2021
Q3 | $915K | Buy |
6,288
+863
| +16% | +$126K | 0.63% | 82 |
|
|
2021
Q2 | $1.06M | Buy |
5,425
+3,977
| +275% | +$779K | 0.72% | 59 |
|
|
2021
Q1 | $262K | Buy |
+1,448
| New | +$262K | 0.26% | 103 |
|